Ten63 Therapeutics (Series A(+))

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Marcel Frenkel, Jonathan Jou, Mark Hallen
Company Description
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.
Market
Human Health
Location
United States

Links
Back to Home Back to Biopharma Deals View Funding Announcement